Salvage treatment of methicillin-resistant staphylococcal endocarditis with ceftaroline: A multicentre observational study

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 7, 2014, Pages 2010-2013

  Tattevin, Pierre ^a,b   Boutoille, David ^b,c   Vitrat, Virginie ^d   Van grunderbeeck, Nicolas ^e   Revest, Matthieu ^a,b   Dupont, Mathieu ^f   Alfandari, Serge ^g   Stahl, Jean Paul ^h  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Association Pour l'Etude et la Prévention de l'Endocardite Infectieuse   (France)

^c HÔTEL DIEU   (France)

^d Department of Cardiology   (France)

^e Department of Neurology   (France)

^f Broussais General Hospital   (France)

^g Gustave Dron Hospital   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cephalosporins; Coagulase negative staphylococci; Methicillin resistant staphylococcus aureus

Indexed keywords

CEFTAROLINE; CEPHALOSPORIN; DAPTOMYCIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

BACTERIAL ENDOCARDITIS; BACTERICIDAL ACTIVITY; COMMUNITY ACQUIRED PNEUMONIA; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCAL ENDOCARDITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PROSTHETIC VALVE ENDOCARDITIS; SALVAGE THERAPY; ADULT; AGED; CLINICAL TRIAL; DRUG EFFECTS; ENDOCARDITIS, BACTERIAL; FEMALE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PENICILLIN RESISTANCE; PROCEDURES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; SALVAGE THERAPY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME;

EID: 84902491079     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku085     Document Type: Letter

References (10)

1. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-413.
2. Flamm RK, Sader HS, Farrell DJ et al. Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance program. Antimicrob Agents Chemother 2012; 56: 2933-40.
3. Laudano JB. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother 2011; 66 Suppl 3: iii11-18.
4. Jacqueline C, Caillon J, Le Mabecque V.et al. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycinintermediate Staphylococcus aureus in a rabbit endocarditis model. Antimicrob Agents Chemother 2007; 51: 3397-400.
5. Jacqueline C, Amador G, Batard E et al. Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptideintermediate Staphylococcus aureus. J Antimicrob Chemother 2011; 66: 863-6.
6. Ho TT, Cadena J, Childs LM et al. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother 2012; 67: 1267-70.
7. Jongsma K, Joson J, Heidari A. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report. J Antimicrob Chemother 2013; 68: 1444-5.
8. Lin JC, Aung G, Thomas A et al. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients. J Infect Chemother 2013; 19: 42-9.
9. Polenakovik HM, Pleiman CM. Ceftaroline for methicillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature. Int J Antimicrob Agents 2013; 42: 450-5.
10. Rose WE, Schulz LT, Andes D et al. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrob Agents Chemother 2012; 56: 5296-302.